HALO
Halozyme Therapeutics
HALO
Meridian score78
ResearchNot researched
QualityQuality: 27th percentile
MomentumMomentum: 96th percentile
GrowthGrowth: 49th percentile
ValuationValuation: 26th percentile
ExpectationsExpectations: 89th percentile
Evidence to review
- Financial comparability: Goodwill and intangible assets increased materially; review acquisition effects.
Price and trend
Price$128.01
1M+12.4%
3M+53.4%
6M+98.5%
52w position99.9%
From high-0.1%
Relative volume0.5x
As ofOct 26, 2026
Above 21d: yesAbove 50d: yesAbove 200d: yes50d over 200d: yes